Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters in Response to Previous Publication
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Systematic Reviews and Meta-analysis
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF

Translate this page into:

Letter to the Editor - Therapy Letter
2018:84:4;491-495
doi: 10.4103/ijdvl.IJDVL_1169_16
PMID: 29667611

Metronidazole as a monotherapy in the management of granulomatous cheilitis

Swagata Tambe1 , Priyanka Patil1 , Ashwini Modi2 , Hemangi Jerajani3
1 Department of Dermatology, Topiwala National Medical College and BYL Nair Hospital, Mumbai, Maharashtra, India
2 Gokuldham Medical Center, Mumbai, Maharashtra, India
3 Department of Dermatology, MGM Medical College and Hospital, Mumbai, Maharashtra, India

Correspondence Address:
Swagata Tambe
19/558, Udyan Society, Nehru Nagar, Kurla East, Mumbai - 400 024, Maharashtra
India
Published: 17-Apr-2018
How to cite this article:
Tambe S, Patil P, Modi A, Jerajani H. Metronidazole as a monotherapy in the management of granulomatous cheilitis. Indian J Dermatol Venereol Leprol 2018;84:491-495
Copyright: (C)2018 Indian Journal of Dermatology, Venereology, and Leprology

Sir,

Granulomatous cheilitis, also known as orofacial granulomatosis, comprises a group of diseases characterized by noncaseating granulomatous inflammation affecting the soft tissues of the oral and maxillofacial region.[1] It is characterized by a chronic and relapsing course. Intraoral sites such as tongue, gingiva and buccal mucosa can also be affected rarely.[2] Various treatment modalities have been tried with variable success rates. Combination therapy with intralesional triamcinolone and clofazimine or dapsone is one of the most commonly used treatment options.[3] Other reported treatments include prednisone, hydroxychloroquine, sulfasalazine, antihistamines, tetracyclines, metronidazole, macrolides, thalidomide and infliximab; all of these have limitations of their own.

We report two cases of granulomatous cheilitis managed with metronidazole as a monotherapy. Metronidazole is cheap and easily available and associated with minimal side effects, even if taken for a longer duration.

Two females, aged 30 years and 10 years, presented with complaints of swelling of lips for 1 year and 6 months, respectively. In the first case, the swelling involved both the lips and was associated with diffuse facial swelling. In the second case, swelling was localized to the upper lip and gums.

Both the patients did not give history of precipitating factors such as seasonal variation, premenstrual flare, drug ingestion or change of residence prior to appearance of lesions. There was no history of any systemic symptoms suggestive of allergic contact dermatitis, angioedema or diffuse facial edema due to renal involvement in the first case.

Cutaneous examination in the first case revealed macrocheilia of both upper and lower lips with diffuse facial edema [Figure - 1] and [Figure - 2], whereas examination of the second case revealed macrocheilia of the upper lip with gingival hyperplasia [Figure - 3] and [Figure - 4]. On palpation in both the cases, lips were rubbery in consistency and nontender. Features such as facial palsy and scrotal tongue seen in Melkersson–Rosenthal syndrome were absent in both patients. The rest of the oral cavity examination was normal. There was no evidence of lymphadenopathy.

Figure 1: Macrocheilia of both upper and lower lips with diffuse facial edema in first patient
Figure 2: Macrocheilia of upper and lower lips with fissuring and scaling
Figure 3: Macrocheilia of upper lip with mild erythema and scaling in the second patient
Figure 4: Macrocheilia of upper lip with gingival hyperplasia

With a provisional diagnosis of granulomatous cheilitis, we investigated the patients. Both the patients' hemogram, blood sugar levels, biochemistry profile and X-ray chest were normal. Angiotensin converting enzyme levels were 26 U/L (Normal, 8–52 U/L) in the first case and 34 U/L (Normal, 8–52 U/L)] in the second case. Biopsy of the first patient revealed irregular hyperplastic epidermis, dermal edema and diffuse granulomatous inflammatory infiltrate in the upper and mid dermis [Figure - 5] and [Figure - 6]. The inflammatory infiltrate consisted of lymphocytes, epithelioid cells and multiple Langhans and foreign body type giant cells, suggesting the diagnosis of granulomatous cheilitis. Biopsy of the second patient revealed hyperplastic epidermis with multiple well-defined edematous granulomata in the upper and mid dermis consisting of lymphocytes, epithelioid cells and giant cells [Figure - 7] and [Figure - 8]. Patch test was not done in either of the patients.

Figure 5: Dermal edema and diffuse granulomatous inflammatory infiltrate in the upper and mid dermis consisted of lymphocytes, epithelioid cells and giant cells (Hematoxylin and Eosin, ×100)
Figure 6: Inflammatory infiltrate consisted of multiple giant cells, epithelioid cells and lymphocytes (Hematoxylin and Eosin, ×400)
Figure 7: Hyperplastic epidermis with multiple well-defined edematous granuloma in the upper and mid dermis (Hematoxylin and Eosin, ×400)
Figure 8: Granuloma consisting of epithelioid cells, giant cells and lymphocytes (Hematoxylin and Eosin, ×100)

Both patients were treated with metronidazole 400 mg three times a day for 2 months initially and then twice daily for 2 months and finally once daily for 2 months. The second patient underwent gingivoplasty in addition to oral metronidazole. Both patients showed excellent response to the treatment without side effects and recurrence, enabling us to stop the treatment completely [Figure - 9], [Figure - 10], [Figure - 11]. Both patients did not show any recurrence 8 months and 5 months after discontinuation of treatment, respectively.

Figure 9: Improvement after treatment in the first patient
Figure 10: Improvement in lip swelling after treatment in the second patient
Figure 11: Reduction in gingival hyperplasia in the second patient after treatment with metronidazole and gingivoplasty

Granulomatous cheilitis, described by Meischer in 1945, is defined as a painless chronic recurrent swelling of the lips secondary to lymphatic obstruction by granulomatous proliferation. It is the most common monosymptomatic form of Melkersson–Rosenthal syndrome. Melkersson–Rosenthal syndrome is a rare disease characterized by the classical triad of edema of the lips and/or face, fissured tongue (lingua plicata) and relapsing peripheral facial nerve paralysis.[4]

The etiology of granulomatous cheilitis is poorly understood. Monoclonal lymphocytic expression secondary to chronic antigenic stimulation, cytokine production leading to granuloma formation and a cell-mediated hypersensitivity reaction have been suggested. Various factors such as genetic, allergic, infectious odontogenic foci, autoimmune mechanism and association of systemic diseases, such as Crohn's disease, sarcoidosis and Wegener's granulomatosis, have been implicated. Various substances such as chocolates, food additives, cinnamon compounds, benzoates, gold, mercury and nickel have been linked to the pathogenesis of the disease.[5]

Disease onset usually occurs in early adulthood with no sexual predilection. It is characterized by persistent, recurrent, diffuse, nontender, nonpitting, soft-to-firm swelling of one or both lips that eventually becomes permanent, leading to possible facial distortion. The typical course of granulomatous cheilitis is relapsing and remitting. Involvement of the upper lip is the most common, followed by the lower lip, cheeks, chin, periorbital region and eyelids. Involvement of the oral mucosa includes gingival hypertrophy, erythema, pain and erosions. The tongue may develop fissures, edema, paresthesia, erosions or taste alterations. Cobblestone appearance may be seen in the buccal mucosa, while papules, erosions and ulcers are seen on the palate.[6]

Histologically, the diagnosis lies in the demonstration of granuloma formation, consisting of collections of epithelioid histiocytes and Langhans giant cells. Differential diagnoses of granulomatous cheilitis are summarized in [Table - 1].[7]

Table 1: Differential diagnoses of Granulomatous cheilitis

Intralesional corticosteroids with or without immunomodulators are the first line of treatment followed by oral corticosteroids. However, relapses are common with the use of corticosteroids, and long-term treatment may be required. Second line treatment modalities include biologics (infliximab, adlimumab), clofazamine, oral corticosteroids with minocycline or metronidazole. Third line therapies include thalidomide, hydroxychloroquine, tranilast and danazol.[8] In severe or recalcitrant cases, cheiloplasty and radiotherapy are considered by some but are rarely needed.

In the first patient, we decided to start intralesional steroids and metronidazole but the patient was not willing to take intralesional steroids, hence, metronidazole was started as a monotherapy. As the patient showed significant improvement within 2 weeks of metronidazole monotherapy, oral and intralesional steroids were not added and metronidazole was continued. With this experience, the second patient was started on metronidazole monotherapy directly, and she also showed remarkable improvement.

Metronidazole is a nitroimidazole drug used as an antiprotozoal and antibacterial agent. Apart from its antimicrobial action, metronidazole has been found to have anti-inflammatory, immunosuppressive and anti-itching effects.[9] It induces a significant decrease in delayed-type hypersensitivity reaction, phagocytic activity (assessed by phagocytic capacity and phagocytic index) as well as tumor necrosis factor-alpha secretion by peritoneal macrophages. It has been used in chronic inflammatory conditions such as acne and rosacea. It has also been used in lichen planus with variable success, and has been suggested as an alternative therapy for cutaneous and oral lichen planus. Its effect in granulomatous cheilitis could be secondary to its anti-inflammatory effects.

Metronidazole has been found effective in granulomatous cheilitis in combination with oral steroids. This article highlights its effectiveness as a monotherapy which has not been mentioned before.[8] Considering the chronic nature of the disease, side effects of oral steroids and reluctance to taking intralesional steroids over lips and perioral area (as seen in our patients), monotherapy with metronidazole appears to be a good option.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form, the patients have given their consent for their images and other clinical information to be reported in the journal. The patients understand that name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References
1.
Sciubba JJ, Said-Al-Naief N. Orofacial granulomatosis: Presentation, pathology and management of 13 cases. J Oral Pathol Med 2003;32:576-85.
[Google Scholar]
2.
Bansal M, Singh N, Patne S, Singh SK. Orofacial granulomatosis affecting lip and gingiva in a 15-year-old patient: A rare case report. Contemp Clin Dent 2015;6:S94-6.
[Google Scholar]
3.
Sobjanek M, Michajłowski I, Zelazny I, Medrzycka-Dabrowska W, Włodarkiewicz A. What is the most effective treatment of cheilitis granulomatosa in Melkersson-Rosenthal syndrome? J Eur Acad Dermatol Venereol 2010;24:364-5.
[Google Scholar]
4.
Muhammed K, Nandakumar G, Thomas S. Granulomatous cheilitis evolving into Melkersson-Rosenthal syndrome with bilateral facial palsy. Indian J Dermatol Venereol Leprol 2004;70:313-4.
[Google Scholar]
5.
Muellegger RR, Weger W, Zoechling N, Kaddu S, Soyer HP, El Shabrawi-Caelen L, et al. Granulomatous cheilitis and Borrelia burgdorferi: Polymerase chain reaction and serologic studies in a retrospective case series of 12 patients. Arch Dermatol 2000;136:1502-6.
[Google Scholar]
6.
Neville BW, Damm DD, Allen CM, Bouquot JE, editors. Oral and Maxillofacial Pathology. 2nd ed. Toronto, Canada: W.B. Saunders Company; 2002.
[Google Scholar]
7.
Allen CM, Camisa C, Hamzeh S, Stephens L. Cheilitis granulomatosa: Report of six cases and review of the literature. J Am Acad Dermatol 1990;23:444-50.
[Google Scholar]
8.
Lam C, Anderson BE. Granulomatous cheilitis. In: Lebwohl MG, Heymann WR, Berth-Jones J, Coulson I, editors. Treatment of Skin Disease e-Book: Comprehensive Therapeutic Strategies. 5th ed. China: Elsevier; 2018. p. 312-5.
[Google Scholar]
9.
Nishimuta K, Ito Y. Effects of metronidazole and tinidazole ointments on models for inflammatory dermatitis in mice. Arch Dermatol Res 2003;294:544-51.
[Google Scholar]

Fulltext Views
1,206

PDF downloads
242
Show Sections